Files
Download Full Text (527 KB)
Contents
- A New Source of Stem Cells
- House Call: Complementary and Alternative Medicine: Sorting through the Choices
- DiaLog: Risks and Benefits of Phase I Oncology Trials, by Razelle Kurzrock, MD, Professor, Division of Cancer Medicine Phase I Program, and Robert S. Benjamin, MD, Professor, Department of Sarcoma Medical Oncology
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
2005
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Shpall, Elizabeth; McMannis, John; Kiran, Sufira; Camacho, Luis; Walker, Cheryl, 1955-; Cook, Jennifer; Keating, Michael J.; Kurzrock, Razelle; Benjamin, Robert S.; Stem Cells; Blood Banks; Clinical Trials as Topic; HLA Antigens; Cord Blood Stem Cell Transplantation; Leukodystrophy, Globoid Cell; Clinical Trials, Phase I as Topic; Prenatal Exposure Delayed Effects; Estrogens; Bone Marrow Examination; Complementary Therapies
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Norwood, Don; Kurzrock, Razelle MD; and Benjamin, Robert S. MD, "OncoLog, Volume 50, Number 09, September 2005" (2005). OncoLog MD Anderson's Report to Physicians (All issues). 142.
https://openworks.mdanderson.org/oncolog/142
Conditions Governing Access
Open
